Public Sector Pension Investment Board Has $2.09 Million Stock Holdings in AVANOS MEDICAL, INC. $AVNS

Key Points

• The Public Sector Pension Investment Board increased its stake in AVANOS MEDICAL by 26.7% during Q1, acquiring an additional 30,662 shares.
• Director Gary Blackford bought 40,000 shares of AVANOS MEDICAL at $10.99 per share, enhancing his ownership significantly.
• AVANOS MEDICAL's most recent earnings report revealed a quarterly EPS of $0.17, missing estimates by $0.01, despite revenues of $175 million exceeding expectations of $165.5 million.

Public Sector Pension Investment Board boosted its holdings in AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) by 26.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,704 shares of the company's stock after acquiring an additional 30,662 shares during the quarter. Public Sector Pension Investment Board owned 0.32% of AVANOS MEDICAL worth $2,088,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in AVNS. Comerica Bank boosted its stake in shares of AVANOS MEDICAL by 3.4% during the 4th quarter. Comerica Bank now owns 22,903 shares of the company's stock worth $365,000 after acquiring an additional 755 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of AVANOS MEDICAL by 3.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company's stock worth $411,000 after acquiring an additional 901 shares in the last quarter. US Bancorp DE boosted its position in shares of AVANOS MEDICAL by 7.7% in the first quarter. US Bancorp DE now owns 15,184 shares of the company's stock worth $218,000 after buying an additional 1,091 shares during the period. EP Wealth Advisors LLC boosted its position in shares of AVANOS MEDICAL by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after buying an additional 1,289 shares during the period. Finally, Azzad Asset Management Inc. ADV boosted its position in shares of AVANOS MEDICAL by 3.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 41,039 shares of the company's stock worth $588,000 after buying an additional 1,404 shares during the period. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on AVNS. Wall Street Zen cut AVANOS MEDICAL from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. Zacks Research raised AVANOS MEDICAL to a "hold" rating in a research report on Tuesday, August 12th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, AVANOS MEDICAL currently has an average rating of "Hold".

Insiders Place Their Bets

In related news, Director Gary Blackford acquired 40,000 shares of the firm's stock in a transaction on Wednesday, August 13th. The shares were bought at an average cost of $10.99 per share, with a total value of $439,600.00. Following the completion of the acquisition, the director owned 40,000 shares of the company's stock, valued at $439,600. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.64% of the stock is currently owned by company insiders.

AVANOS MEDICAL Stock Down 0.3%

NYSE AVNS traded down $0.04 during trading on Tuesday, hitting $11.56. 552,228 shares of the company traded hands, compared to its average volume of 812,369. AVANOS MEDICAL, INC. has a 12 month low of $9.30 and a 12 month high of $25.36. The business has a fifty day simple moving average of $11.64 and a 200 day simple moving average of $12.92. The company has a current ratio of 2.64, a quick ratio of 1.58 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $536.52 million, a P/E ratio of -1.15 and a beta of 1.12.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $175.00 million for the quarter, compared to the consensus estimate of $165.50 million. AVANOS MEDICAL had a negative net margin of 66.89% and a positive return on equity of 6.16%. During the same quarter last year, the business earned $0.34 earnings per share. AVANOS MEDICAL has set its FY 2025 guidance at 0.750-0.950 EPS. As a group, sell-side analysts predict that AVANOS MEDICAL, INC. will post 1.32 EPS for the current year.

AVANOS MEDICAL Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.